Abstract
What a Clinical Trial Related to Elective Labor Induction Could Mean for the Future of Birth in the United States Many perinatal providers are unaware that a large, multi-site clinical trial is currently underway to compare elective induction of labor at 39 weeks gestation to expectant management in nulliparous women with single, vertex fetuses. This study, known as A Randomized Trial of Induction Versus Expectant Management (ARRIVE), has the capacity to radically change the way late pregnancy and labor are managed in the United States (ClinicalTrials.gov, 2015).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Obstetric, Gynecologic & Neonatal Nursing
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
